Smoking and Atherosclerotic Cardiovascular Disease: Part I: Atherosclerotic Disease Process

• Kannel W : Contributions of the Framingham study to the conquest of coronary artery disease.Am. J. Cardiol.62, 1109–1112 (1988).
   PubMed Web of Science ®Google Scholar
• Bradford Hill A : The environment and disease: association or causation.Proc. R. Soc. Med.58, 295–300 (1965).
   PubMedGoogle Scholar
• Greenlee RT , Hill-HarmonMB, MurrayT, ThunM: Cancer statistics, 2001.CA Cancer J. Clin.51, 15–36 (2001).
   PubMed Web of Science ®Google Scholar
• Willett WC , GreenA, StampferMJet al.: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.N. Engl. J. Med.317, 1303–1309 (1987).
   PubMed Web of Science ®Google Scholar
• McGinnis JM , FoegeWH: Actual causes of death in the united states.J. Am. Med. Assoc.270, 2207–2212 (1993).
   PubMed Web of Science ®Google Scholar
• Nilsson S , CarstensenJM, PershagenG: Mortality among male and female smokers in sweden: a 33 year follow up.J. Epidemiol. Commun. Health55, 825–830 (2001).
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention: Annual smoking-attributable mortality, years of potential life lost, and economic costs – United States, 1995–1999. MMWR Morb. Mortal. Wkly Rep.51, 300–303 (2002).
   PubMedGoogle Scholar
• Ezzati M , HenleySJ, ThunMJ, LopezAD: Role of smoking in global and regional cardiovascular mortality.Circulation112, 489–497 (2005).
   PubMed Web of Science ®Google Scholar
• Bronnum-Hansen H : Predicted effect of smoking cessation of tobacco-related mortality.Ugeskr. Laeg.162, 5772–5777 (2000).
   PubMedGoogle Scholar
• Feenstra TL , van GenugtenML, HoogenveenRT, WoutersEF, Rutten-van MolkenMP: The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in The Netherlands. Am. J. Respir. Crit. Care Med.164, 590–596 (2001).
   PubMed Web of Science ®Google Scholar
• Jones A : Causes and effects of chronic obstructive pulmonary disease.Br. J. Nurs.10, 845–850 (2001).
   PubMedGoogle Scholar
• Lundback B , LindbergA, LindstromMet al.: Not 15 but 50% of smokers develop COPD? – Report from the obstructive lung disease in northern Sweden studies.Respir. Med.97, 115–122 (2003).
   PubMed Web of Science ®Google Scholar
• Siafakas NM , TzortzakiEG: Few smokers develop COPD. Why.Respir. Med.96, 615–624 (2002).
   PubMed Web of Science ®Google Scholar
• Hyland A , VenaC, BauerJet al.: Cigarette smoking-attributable mobidity united states 2000.Morb. Mortal. Wkly Rep.52, 842–844 (2003).
   PubMedGoogle Scholar
• Ando M , WakaiK, SekiNet al.: Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan collaborative cohort study.Int. J. Cancer105, 249–254 (2003).
   PubMed Web of Science ®Google Scholar
• Darby SC , DollR, StrattonIM: Trends in mortality from smoking-related diseases in England and Wales. In: Nicotine, Smoking, and the Low Tar Programme. Wald N, Froggatt P (Eds). Oxford University Press, Oxford, UK (1989).
   Google Scholar
• Institute of Medicine: Clearing the smoke: assessing the science base for tobacco harm reduction. Executive summary, research conclusions and recommendations. Institute of Medicine, Washington, DC, USA (2001).
   Google Scholar
• Ebert RV : Cessation of cigarette smoking and pulmonary disease.J. Am. Med. Assoc.240, 2159–2161 (1978).
   PubMed Web of Science ®Google Scholar
• Doll R , PetoR, WheatleyK, GrayR, SutherlandI: Mortality in relation to smoking: 40 years‘ observations on male british doctors.Br. Med. J.309, 901–911 (1994).
   PubMed Web of Science ®Google Scholar
• Wu MS , WuCY, ChenCJ, LinMT, ShunCT, LinJT: Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese.Int. J. Cancer104, 617–623 (2003).
   PubMed Web of Science ®Google Scholar
• Kato I , NomuraA, StemmermannG, ChyouP: A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet.Am. J. Epidemiol.135, 521–530 (1992).
   PubMed Web of Science ®Google Scholar
• Department of Health, Education and Welfare: Smoking and health: a report of the US Surgeon General. US DHEW, Washington, DC, USA publication no. (PHS) 79–50066 (1979).
   Google Scholar
• Rhodes J , GAT: Smoking: good or bad for inflammatory bowel disease.Gastroenterology106, 807–810 (1994).
   PubMed Web of Science ®Google Scholar
• Calkins BM : A meta-analysis of the role of smoking in inflammatory bowel disease.Dig. Dis. Sci.34, 1841–1854 (1989).
   PubMed Web of Science ®Google Scholar
• Duffy LC , ZieleznyMA, MarshallJRet al.: Cigarette smoking and risk of clinical relapse in patients with Crohn‘s disease.Am. J. Prev. Med.6, 161–166 (1990).
   PubMed Web of Science ®Google Scholar
• Cottone M , RosselliM, OrlandoAet al.: Smoking habits and recurrence in Crohn‘s disease.Gastroenterology106, 643–648 (1994).
   PubMed Web of Science ®Google Scholar
• Kurata JH , Kantor-FishS, FranklH, GodbyP, VadheimCM: Crohn‘s disease among ethnic groups in a large health maintenance organization.Gastroenterology102, 1940–1948 (1992).
   PubMed Web of Science ®Google Scholar
• Sutherland LR , RamcharanS, BryantH, FickG: Effect of cigarette smoking on recurrence of Crohn‘s disease.Gastroenterology98, 1123–1128 (1990).
   PubMed Web of Science ®Google Scholar
• Hujoel PP , DrangsholtM, SpiekermanC, DeRouenTA: Periodontitis-systemic disease associations in the presence of smoking – causal or coincidental.Periodontol. 200030, 51–60 (2002).
   PubMed Web of Science ®Google Scholar
• Haber J , WattlesJ, CrowleyM, MandellR, JoshipuraK, KentRL: Evidence for cigarette smoking as a major risk factor for periodontitis.J. Periodontol.64, 16–23 (1993).
   PubMed Web of Science ®Google Scholar
• Haber J , KentRL: Cigarette smoking in a periodontal practice.J. Periodontol.63, 100–106 (1992).
   PubMed Web of Science ®Google Scholar
• Bergstrom J : Tobacco smoking and supragingival dental calculus.J. Clin. Periodontol.26, 541–547 (1999).
   PubMed Web of Science ®Google Scholar
• Haber J : Smoking is a major risk factor for periodontitis.Curr. Opin. Periodontol.12–18 (1994).
   PubMedGoogle Scholar
• Haber J : Cigarette smoking: a major risk factor for periodontitis.Compendium15, 1002, 1004–1008 (1994).
   Google Scholar
• Hujoel PP : Does chronic periodontitis cause coronary heart disease? A review of the literature.J. Am. Dent. Assoc.133(Suppl.), 31S–36S (2002).
   PubMed Web of Science ®Google Scholar
• Horning GM , HatchCL, CohenME: Risk indicators for periodontitis in a military treatment population.J. Periodontol.63, 297–302 (1992).
   PubMed Web of Science ®Google Scholar
• Locker D , LeakeJ: Risk indicators and risk markers for periodontal disease experience in older adults living independently in Ontario, Canada.J. Dent. Res.72, 9–17 (1993).
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention: Annual smoking-attributable morbidity United States, 2000. MMWR Morb. Mortal. Wkly Rep.52, 842–844 (2003).
   PubMedGoogle Scholar
• Chen Z , BorehamJ: Smoking and cardiovascular disease.Semin. Vasc. Med.2, 243–252 (2002).
   PubMedGoogle Scholar
• Ross R : Atherosclerosis – an inflammatory disease.N. Engl. J. Med.340, 115–126 (1999).
   PubMed Web of Science ®Google Scholar
• Szmitko PE , WangCH, WeiselRD, JeffriesGA, AndersonTJ, VermaS: Biomarkers of vascular disease linking inflammation to endothelial activation: part II.Circulation108, 2041–2048 (2003).
   PubMed Web of Science ®Google Scholar
• Szmitko P , WangC, WeiselR, de AmeidaJ, AndersonT, VermaS: New markers of inflammation and endothelial cell activation – part I. Circulation108, 1917–1923 (2003).
   PubMed Web of Science ®Google Scholar
• Badimon JJ , FusterV, ChesebroJH, BadimonL: Coronary atherosclerosis. A multifactorial disease.Circulation87(3 Suppl.), II3–I16 (1993).
   PubMed Web of Science ®Google Scholar
• Davignon J : The lipid hypothesis. Pathophysiological basis.Arch. Surg.113, 28–34 (1978).
   PubMedGoogle Scholar
• Berliner J , NavabM, FogelmanAet al.: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.Circulation91, 2488–2496 (1995).
   PubMed Web of Science ®Google Scholar
• Lobstein JF : Traîte d‘Anatomie Pathologique (Volume 1). Imprimierie de FG Levrault, Imprimeur du Roi (Eds). Paris and Strasbourg, France (1829).
   Google Scholar
• Keys A : Human atherosclerosis and diet.Circulation5, 115–118 (1952).
   PubMed Web of Science ®Google Scholar
• Virchow R : Über die parenchymatöse entzündung virchows.Arch. Path. Anat.4, 261–324 (1852).
   Google Scholar
• Rokitansky C : Über eine der Wichtigsten Krankheiten der Arterien (Volume 4). Hof KK, Staatsdruckerei (Eds). Vienna, Austria, 1–72 (1852).
   Google Scholar
• Anitschkow N : Über die atheroskerose der aorta beim kaninchen und über deren entstehungsbedingungen.Beitr. Pathol. Anat.59, 306–348 (1914).
   Google Scholar
• Biermann L , RossR: Aging and atherosclerosis.Atheroscler. Rev.2, 79–85 (1977).
   Google Scholar
• Aschoff L : Arteriosklerose.Medizinische Klinik (Beiheft 1) 10 (1914).
   Google Scholar
• Hueck W : Über das mesenchym. Die bedeutung seiner entwicklung und seines baues fur die pathologie.Beitr. Pathol. Anat.66, 330–366 (1920).
   Google Scholar
• Doerr W : Morphologische untersuchungen zur entstehung der aortensklerose.Dtsch. Med. Wochenschr.85, 1401–1405 (1960).
   Google Scholar
• Dugiud J : Thrombosis as a factor of pathogenesis of coronary atherosclerosis.J. Pathol. Bacteriol.58, 207–211 (1948).
   Google Scholar
• Hauss W , Junge-HülsingG: Veränderungen des bindegewebsstoffwechsels durch toxische, infektiöse und allergische einflüsse.Z. Rheumaforsch.20, 161–175 (1961).
   PubMedGoogle Scholar
• Ross R , GlomsetJ: Atherosclerosis and the smooth muscle – proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.Science80, 1332–1339 (1973).
   Google Scholar
• Ross R , GlomsetJ, KariyaBet al.: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.Proc. Natl Acad. Sci. USA71, 1207–1211 (1976).
   Web of Science ®Google Scholar
• Ross MA , CrosleyLK, BrownKMet al.: Plasma concentrations of carotenoids and antioxidant vitamins in scottish males: influences of smoking.Eur. J. Clin. Nutr.49, 861–865 (1995).
   PubMed Web of Science ®Google Scholar
• Ross R : The pathogenesis of atherosclerosis: a perspective for the 1990s.Nature362, 801–809 (1993).
   PubMed Web of Science ®Google Scholar
• Ross R , GlomsetJ, HarkerL: Response to injury and atherogenesis.Am. J. Pathol.86, 675–684 (1977).
   PubMed Web of Science ®Google Scholar
• Munro J , CotranR: The pathogenesis of atherosclerosis: atherogenesis and inflammation.Lab. Invest.58, 249–261 (1988).
   PubMed Web of Science ®Google Scholar
• Bauriedel G , AndrieR, LikunguJAet al.: Persistenz von Chlamydia pneumonia in koronarem plaquegewebe. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].Dtsch. Med. Wochenschr.124, 1408–1413 (1999).
   PubMed Web of Science ®Google Scholar
• Grayston JT , KuoCC, CoulsonASet al.: Chlamydia pneumoniae (twar) in atherosclerosis of the carotid artery [see comments].Circulation92, 3397–3400 (1995).
   PubMed Web of Science ®Google Scholar
• Jackson LA , CampbellLA, SchmidtRAet al.: Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis.Am. J. Pathol.150, 1785–1790 (1997).
   PubMed Web of Science ®Google Scholar
• Jackson LA , CampbellLA, SchmidtRAet al.: Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma.J. Infect. Dis.181(Suppl. 3), S447–S448 (2000).
   PubMed Web of Science ®Google Scholar
• Kuo CC , GraystonJT, CampbellLA, GooYA, WisslerRW, BendittEP: Chlamydia pneumoniae (twar) in coronary arteries of young adults (15–34 years old).Proc. Natl Acad. Sci. USA92, 6911–6914 (1995).
   PubMed Web of Science ®Google Scholar
• Juvonen J , JuvonenT, LaurilaAet al.: Immunohistochemical detection of Chlamydia pneumoniae in abdominal aortic aneurysms.Ann. NY Acad. Sci.800, 236–238 (1996).
   PubMed Web of Science ®Google Scholar
• Maass M : Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences. [Persistenz von Chlamydiae pneumoniae in humanem artzeriosklerotischem plaquematerial].Herz23, 178–184 (1998).
   PubMedGoogle Scholar
• Maass M , GieffersJ, SolbachW: Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.Herz25, 68–72 (2000).
   PubMed Web of Science ®Google Scholar
• Melnick SL , ShaharE, FolsomARet al.: Past infection by Chlamydia pneumoniae strain twar and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) study investigators.Am. J. Med.95, 499–504 (1993).
   PubMed Web of Science ®Google Scholar
• Miettinen H , LehtoS, SaikkuPet al.: Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.Eur. Heart J.17, 682–688 (1996).
   PubMed Web of Science ®Google Scholar
• Patel P , MendallMA, CarringtonDet al.: Association of helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.Br. Med. J.311, 711–714 (1995).
   PubMed Web of Science ®Google Scholar
• Ramirez JA : Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/atherosclerosis study group.Ann. Intern. Med.125, 979–982 (1996).
   PubMed Web of Science ®Google Scholar
• Shor A , KuoCC, PattonDL: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.S. Afr. Med. J.82, 158–161 (1992).
   PubMed Web of Science ®Google Scholar
• Thom DH , GraystonJT, SiscovickDS, WangSP, WeissNS, DalingJR: Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.J. Am. Med. Assoc.268, 68–72 (1992).
   PubMed Web of Science ®Google Scholar
• Fabricant C , FabricantJ, LitrentaM, MinickC: Herpes-virus induced atherosclerosis. In: Viruses in Naturally Occurring Cancers. Essex M, Todara G, zur Hausen H (Eds). Cold Spring Harbor Laboratory, NY, USA, 7, 1251–1258 (1980).
   Google Scholar
• Fabricant C , FabricantJ, LitrentaM, MinickC: Virus-induced atherosclerosis.J. Exp. Med.148, 335–340 (1978).
   PubMed Web of Science ®Google Scholar
• Saikku P , LeinonenM, MattilaKet al.: Serological evidence of an association of a novel chlamydia, twar, with chronic coronary heart disease and acute myocardial infarction.Lancet2, 983–986 (1988).
   PubMed Web of Science ®Google Scholar
• The Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results. I. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J. Am. Med. Assoc.251, 365–374 (1984).
   PubMed Web of Science ®Google Scholar
• Benditt EP , BendittJM: Evidence for a monoclonal origin of human atherosclerotic plaques.Proc. Natl Acad. Sci. USA70, 1753–1756 (1973).
   PubMed Web of Science ®Google Scholar
• Brown MS , GoldsteinJL: A receptor-mediated pathway for cholesterol homeostasis.Science232, 34–47 (1986).
   PubMed Web of Science ®Google Scholar
• Arbustini E , MorbiniP, BelloBD, PratiF, SpecchiaG: From plaque biology to clinical setting.Am. Heart J.138, S55-S60 (1999).
   PubMed Web of Science ®Google Scholar
• Bhakdi S : Complement and atherogenesis: the unknown connection.Ann. Med.30, 503–507 (1998).
   PubMed Web of Science ®Google Scholar
• Ross R , GlomsetJA: The pathogenesis of atherosclerosis (first of two parts).N. Engl. J. Med.295, 369–377 (1976).
   PubMed Web of Science ®Google Scholar
• Ross R : Mechanisms of atherosclerosis – a review.Adv. Nephrol. Necker Hosp.19, 79–86 (1990).
   PubMedGoogle Scholar
• Keaney J , GazianoJ, XuAet al.: Low-dose a-tocopherol improves and high-dose a-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.J. Clin. Invest.93, 844–851 (1994).
   PubMed Web of Science ®Google Scholar
• Fish R , NabelE, SelwynAet al.: Response of coronary arteries of cardiac transplant patients to acetylcholine.J. Clin. Invest.81, 21–31 (1988).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , SorensenKE, GoochVMet al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet340, 1111–1115 (1992).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , AdamsMR, ClarksonPet al.: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults.N. Engl. J. Med.334, 150–154 (1996).
   PubMed Web of Science ®Google Scholar
• Steinberg D , ParthasarathyS, CarewTE, KhooJC, WitztumJL: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.N. Engl. J. Med.320, 915–924 (1989).
   PubMed Web of Science ®Google Scholar
• Steinberg D : Thematic review series: The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part ii: the early evidence linking hypercholesterolemia to coronary disease in humans.J. Lipid Res.46, 179–190 (2005).
   PubMed Web of Science ®Google Scholar
• Steinberg D : Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia.J. Lipid Res.46, 2037–2051 (2005).
   PubMed Web of Science ®Google Scholar
• Aengevaeren W : Beyond lipids – the role of the endothelium in coronary artery disease.Atherosclerosis147(Suppl. 1), S11–S16 (1999).
   PubMed Web of Science ®Google Scholar
• Stehouwer C : Is measurement of endothelial dysfunction useful.Eur. J. Clin. Invest.29, 459–461 (1999).
   PubMed Web of Science ®Google Scholar
• Raitakari O , CelermajerD: Testing for endothelial dysfunction.Ann. Med.32, 293–304 (1999).
   Web of Science ®Google Scholar
• Keaney JF Jr : Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Mol. Aspects Med.21, 99–166 (2000).
   PubMedGoogle Scholar
• Hansen HH , VammenB, JensenMK: [Smoking cessation in patients with stable or unstable ischemic heart disease].Ugeskr. Laeg.161, 3659–3662 (1999).
   PubMedGoogle Scholar
• Libby P , RidkerPM, MaseriA: Inflammation and atherosclerosis.Circulation105, 1135–1143 (2002).
   PubMed Web of Science ®Google Scholar
• Libby P , HanssonGK: Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.Lab. Invest.64, 5–15 (1991).
   PubMed Web of Science ®Google Scholar
• Lopes-Virella MF , VirellaG: Atherosclerosis and autoimmunity.Clin. Immunol. Immunopathol.73, 155–167 (1994).
   PubMedGoogle Scholar
• Lerman A , ZeiherAM: Endothelial function: cardiac events.Circulation111, 363–368 (2005).
   PubMed Web of Science ®Google Scholar
• Haegeli L , QuitzauK, LuescherTF: From endothelial dysfunction to clinical events: concept and update on the encore trials.Eur. Heart J. (Suppl. 3), B12–B19 (2001).
   Google Scholar
• Sriraman R , TookeJE: Endothelial dysfunction and insulin resistance.Metab. Syndr. Relat. Disord.2, 129–136 (2004).
   PubMed Web of Science ®Google Scholar
• Pillarisetti S : Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.Trends Cardiovasc. Med.10, 60–65 (2000).
   PubMed Web of Science ®Google Scholar
• Kohler HP , GrantPJ: Plasminogen-activator inhibitor type 1 and coronary artery disease.N. Engl. J. Med.342, 1792–1801 (2000).
   PubMed Web of Science ®Google Scholar
• Esmon CT , XuJ, GuJMet al.: Endothelial protein c receptor.Thromb. Haemost.82, 251–258 (1999).
   PubMed Web of Science ®Google Scholar
• Esmon CT : The endothelial cell protein c receptor.Thromb. Haemost.83, 639–643 (2000).
   PubMed Web of Science ®Google Scholar
• Prescott SM , McIntyreTM, ZimmermanGA, StafforiniDM: Sol sherry lecture in thrombosis: molecular events in acute inflammation.Arterioscler. Thromb. Vasc. Biol.22, 727–733 (2002).
   PubMed Web of Science ®Google Scholar
• Dittman WA , MajerusPW: Structure and function of thrombomodulin: a natural anticoagulant.Blood75, 329–336 (1990).
   PubMed Web of Science ®Google Scholar
• Takanashi S , HasegawaY, KanehiraYet al.: Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers.Eur. Respir. J.14, 309–314 (1999).
   PubMed Web of Science ®Google Scholar
• Moons AH , LeviM, PetersRJ: Tissue factor and coronary artery disease.Cardiovasc. Res.53, 313–325 (2002).
   PubMed Web of Science ®Google Scholar
• Polgar J , MatuskovaJ, WagnerDD: The p-selectin, tissue factor, coagulation triad.J. Thromb. Haemost.3, 1590–1596 (2005).
   PubMed Web of Science ®Google Scholar
• Muldowney JA, III, VaughanDE: Tissue-type plasminogen activator release: new frontiers in endothelial function. J. Am. Coll. Cardiol.40, 967–969 (2002).
   PubMed Web of Science ®Google Scholar
• Meyer D , GirmaJP: Von willebrand factor: structure and function.Thromb. Haemost.70, 99–104 (1993).
   PubMed Web of Science ®Google Scholar
• Vlot AJ , KoppelmanSJ, BoumaBN, SixmaJJ: Factor viii and von Willebrand factor.Thromb. Haemost.79, 456–465 (1998).
   PubMed Web of Science ®Google Scholar
• Mondino A , ResnatiM, BlasiF: Structure and function of the urokinase receptor.Thromb. Haemost.82(Suppl. 1), 19–22 (1999).
   PubMedGoogle Scholar
• Grand R , TurnellA, GrabhamP: Cellular consequences of thrombin-receptor activation.Biochem. J.313, 353–368 (1996).
   PubMed Web of Science ®Google Scholar
• Bajaj MS , BirktoftJJ, SteerSA, BajajSP: Structure and biology of tissue factor pathway inhibitor.Thromb. Haemost.86, 959–972 (2001).
   PubMed Web of Science ®Google Scholar
• Reutelingsperger C : Annexins: Key regulators of haemostasis, thrombosis, and apoptosis.Thromb. Haemost.86, 413–419 (2001).
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM , BlochKD: The vascular biology of nitric oxide and its role in atherogenesis.Annu. Rev. Med.47, 365–375 (1996).
   PubMed Web of Science ®Google Scholar
• Gewaltig MT , KojdaG: Vasoprotection by nitric oxide: mechanisms and therapeutic potential.Cardiovasc. Res.55, 250–260 (2002).
   PubMed Web of Science ®Google Scholar
• Brown JS , SteeleK: Cigarette smoking and random serum cholesterol levels in a Northern Ireland general practice population of 18- to 20-year-old students and non-students.Br. J. Gen. Pract.46, 665–669 (1996).
   PubMed Web of Science ®Google Scholar
• Barrow SE , WardPS, SleightholmMA, RitterJM, DolleryCT: Cigarette smoking: Profiles of thromboxane- and prostacyclin-derived products in human urine.Biochim. Biophys. Acta993, 121–127 (1989).
   PubMed Web of Science ®Google Scholar
• Kedzierski RM , YanagisawaM: Endothelin system: the double-edged sword in health and disease.Annu. Rev. Pharmacol. Toxicol.41, 851–876 (2001).
   PubMed Web of Science ®Google Scholar
• Best PJ , LermanA: Endothelin in cardiovascular disease: from atherosclerosis to heart failure.J. Cardiovasc. Pharmacol.35, S61–S63 (2000).
   PubMed Web of Science ®Google Scholar
• Palkhiwala SA , FrishmanWH, WarshafskyS: Bradykinin for the treatment of cardiovascular disease.Heart Dis.3, 333–339 (2001).
   PubMedGoogle Scholar
• Shriver Z , LiuD, SasisekharanR: Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions.Trends Cardiovasc. Med.12, 71–77 (2002).
   PubMed Web of Science ®Google Scholar
• Waltenberger J : Modulation of growth factor action: implications for the treatment of cardiovascular diseases.Circulation96, 4083–4094 (1997).
   PubMed Web of Science ®Google Scholar
• Blobe GC , SchiemannWP, LodishHF: Role of transforming growth factor β in human disease.N. Engl. J. Med.342, 1350–1358 (2000).
   PubMed Web of Science ®Google Scholar
• Delafontaine P : Insulin-like growth factor I and its binding proteins in the cardiovascular system.Cardiovasc. Res.30, 825–834 (1995).
   PubMed Web of Science ®Google Scholar
• Bornstein P : Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.J. Cell Biol.130, 503–506 (1995).
   PubMed Web of Science ®Google Scholar
• Breier G : Functions of the VEGF/VEGF receptor system in the vascular system.Semin. Thromb. Hemost.26, 553–559 (2000).
   PubMed Web of Science ®Google Scholar
• Bhakdi S , TorzewskiM, KloucheM, HemmesM: Complement and atherogenesis: Binding of crp to degraded, nonoxidized LDL enhances complement activation.Arterioscler. Thromb. Vasc. Biol.19, 2348–2354 (1999).
   PubMed Web of Science ®Google Scholar
• Carlos TM , HarlanJM: Leukocyte-endothelial adhesion molecules.Blood84, 2068–2101 (1994).
   PubMed Web of Science ®Google Scholar
• Cines DB , PollakES, BuckCAet al.: Endothelial cells in physiology and in the pathophysiology of vascular disorders.Blood91, 3527–3561 (1998).
   PubMed Web of Science ®Google Scholar
• Kharitonov SA , RobbinsRA, YatesD, KeatingsV, BarnesPJ: Acute and chronic effects of cigarette smoking on exhaled nitric oxide.Am. J. Respir. Crit. Care Med.152, 609–612 (1995).
   PubMed Web of Science ®Google Scholar
• Fernandez EJ , LolisE: Structure, function, and inhibition of chemokines.Annu. Rev. Pharmacol. Toxicol.42, 469–499 (2002).
   PubMed Web of Science ®Google Scholar
• Haddad JJ : Cytokines and related receptor-mediated signaling pathways.Biochem. Biophys. Res. Commun.297, 700–713 (2002).
   PubMed Web of Science ®Google Scholar
• Lasky LA : Selectins: Interpreters of cell-specific carbohydrate information during inflammation.Science258, 964–969 (1992).
   PubMed Web of Science ®Google Scholar
• Fukai T , FolzRJ, LandmesserU, HarrisonDG: Extracellular superoxide dismutase and cardiovascular disease.Cardiovasc. Res.55, 239–249 (2002).
   PubMed Web of Science ®Google Scholar
• Harms G , KraftR, GrelleG, VolzB, DerneddeJ, TauberR: Identification of nucleolin as a new l-selectin ligand.Biochem. J.360, 531–538 (2001).
   PubMed Web of Science ®Google Scholar
• Mashima R , WittingPK, StockerR: Oxidants and antioxidants in atherosclerosis.Curr. Opin. Lipidol.12, 411–418 (2001).
   PubMed Web of Science ®Google Scholar
• Mach F , SchonbeckU, SukhovaGKet al.: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40–CD40 ligand signaling in atherosclerosis.Proc. Natl Acad. Sci. USA94, 1931–1936 (1997).
   PubMed Web of Science ®Google Scholar
• Brasier AR , RecinosA, III, EledrisiMS: Vascular inflammation and the renin–angiotensin system. Arterioscler. Thromb. Vasc. Biol.22, 1257–1266 (2002).
   PubMed Web of Science ®Google Scholar
• Laine P , PentikainenMO, WurznerRet al.: Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction.Am. J. Cardiol.90, 404–408 (2002).
   PubMed Web of Science ®Google Scholar
• Gross PL , AirdWC: The endothelium and thrombosis.Semin. Thromb. Hemost.26, 463–478 (2000).
   PubMed Web of Science ®Google Scholar
• Gimbrone MA Jr : Endothelial dysfunction, hemodynamic forces, and atherosclerosis. Thromb. Haemost.82, 722–726 (1999).
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM : Endothelial control of vasomotor function: from health to coronary disease.Circ. J.67, 572–575 (2003).
   PubMed Web of Science ®Google Scholar
• Hambrecht R , WolfA, GielenSet al.: Effect of exercise on coronary endothelial function in patients with coronary artery disease.N. Engl. J. Med.342, 454–460 (2000).
   PubMed Web of Science ®Google Scholar
• Zeiher AM , SchachingerV, MinnersJ: Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.Circulation92, 1094–1100 (1995).
   PubMed Web of Science ®Google Scholar
• Kunsch C , MedfordRM: Oxidative stress as a regulator of gene expression in the vasculature.Circ. Res.85, 753–766 (1999).
   PubMed Web of Science ®Google Scholar
• Dhalla NS , TemsahRM, NetticadanT: Role of oxidative stress in cardiovascular diseases.J. Hypertens.18, 655–673 (2000).
   PubMed Web of Science ®Google Scholar
• Cai H , HarrisonDG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.Circ. Res.87, 840–844 (2000).
   PubMed Web of Science ®Google Scholar
• Horstman LL , JyW, JimenezJJ, AhnYS: Endothelial microparticles as markers of endothelial dysfunction.Front. Biosci.9, 1118–1135 (2004).
   PubMed Web of Science ®Google Scholar
• Jy W , JimenezJJ, ChengPet al.: Endothelial microaprticles (emp) bind and complex with unusually-large multimers of von Willebrand factor (ulvWF) and act as potent induceers of platelet adhesion and aggregation.Blood104, 997a (2004).
   Web of Science ®Google Scholar
• Jy W , MinagarA, JimenezJJet al.: Endothelial microparticles (emp) bind and activate monocytes: elevated emp-monocyte conjugates in multiple sclerosis.Front. Biosci.9, 3137–3144 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatier F , RouxV, AnfossoF, CamoinL, SampolJ, Dignat-GeorgeF: Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity.Blood99, 3962–3970 (2002).
   PubMed Web of Science ®Google Scholar
• Prescott SM , ZimmermanGA, McIntyreTM, StafforiniDM: Inflammation in the vascular wall as an early event in atherosclerosis.Diabetologia40(Suppl. 2), S111–S112 (1997).
   PubMed Web of Science ®Google Scholar
• Napoli C , LermanLO: Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia.Mayo. Clin. Proc.76, 619–631 (2001).
   PubMed Web of Science ®Google Scholar
• Napoli C , IgnarroLJ: Nitric oxide and atherosclerosis.Nitric Oxide5, 88–97 (2001).
   PubMed Web of Science ®Google Scholar
• Forstermann U , ClossEI, PollockJSet al.: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension23, 1121–1131 (1994).
   PubMed Web of Science ®Google Scholar
• Morris SM Jr , BilliarTR: New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol.266, E829–E839 (1994).
   PubMed Web of Science ®Google Scholar
• Nathan C , XieQW: Nitric oxide synthases: roles, tolls, and controls.Cell78, 915–918 (1994).
   PubMed Web of Science ®Google Scholar
• Boger RH , Bode-BogerSM, FrolichJC: The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications.Atherosclerosis127, 1–11 (1996).
   PubMed Web of Science ®Google Scholar
• Hogg N , KalyanaramanB, JosephJ, StruckA, ParthasarathyS: Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis.FEBS Lett.334, 170–174 (1993).
   PubMed Web of Science ®Google Scholar
• Cooke JP : Does adma cause endothelial dysfunction.Arterioscler. Thromb. Vasc. Biol.20, 2032–2037 (2000).
   PubMed Web of Science ®Google Scholar
• Rubanyi GM , VanhouttePM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.Am. J. Physiol.250, H822–H827 (1986).
   PubMed Web of Science ®Google Scholar
• Abu-Soud HM , HazenSL: Nitric oxide is a physiological substrate for mammalian peroxidases.J. Biol. Chem.275, 37524–37532 (2000).
   PubMed Web of Science ®Google Scholar
• Pou S , PouWS, BredtDS, SnyderSH, RosenGM: Generation of superoxide by purified brain nitric oxide synthase.J. Biol. Chem.267, 24173–24176 (1992).
   PubMed Web of Science ®Google Scholar
• Stroes E , de Bruin T, de Valk H et al.: No activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc. Res.36, 445–452 (1997).
   PubMed Web of Science ®Google Scholar
• Xia Y , RomanLJ, MastersBS, ZweierJL: Inducible nitric-oxide synthase generates superoxide from the reductase domain.J. Biol. Chem.273, 22635–22639 (1998).
   PubMed Web of Science ®Google Scholar
• Pritchard KA Jr , Groszek L, Smalley DM et al.: Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ. Res.77, 510–518 (1995).
   PubMed Web of Science ®Google Scholar
• Vasquez-Vivar J , KalyanaramanB, MartasekPet al.: Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors.Proc. Natl Acad. Sci. USA95, 9220–9225 (1998).
   PubMed Web of Science ®Google Scholar
• Moncada S , PalmerRM, HiggsEA: Nitric oxide: physiology, pathophysiology, and pharmacology.Pharmacol. Rev.43, 109–142 (1991).
   PubMed Web of Science ®Google Scholar
• Kubes P , SuzukiM, GrangerDN: Nitric oxide: an endogenous modulator of leukocyte adhesion.Proc. Natl Acad. Sci. USA88, 4651–4655 (1991).
   PubMed Web of Science ®Google Scholar
• Radomski MW , PalmerRM, MoncadaS: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Proc. Natl Acad. Sci. USA87, 5193–5197 (1990).
   PubMed Web of Science ®Google Scholar
• Ginnan R , GuikemaBJ, HalliganKE, SingerHA, Jourd‘heuilD: Regulation of smooth muscle by inducible nitric oxide synthase and nadph oxidase in vascular proliferative diseases.Free Radic. Biol. Med.44, 1232–1245 (2008).
   PubMed Web of Science ®Google Scholar
• Hansson GK , GengYJ, HolmJ, HardhammarP, WennmalmA, JennischeE: Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.J. Exp. Med.180, 733–738 (1994).
   PubMed Web of Science ®Google Scholar
• Kibbe M , BilliarT, TzengE: Inducible nitric oxide synthase and vascular injury.Cardiovasc. Res.43, 650–657 (1999).
   PubMed Web of Science ®Google Scholar
• Ku DN , GiddensDP, ZarinsCK, GlagovS: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.Arteriosclerosis5, 293–302 (1985).
   PubMedGoogle Scholar
• Gnasso A , CaralloC, IraceCet al.: Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects.Circulation94, 3257–3262 (1996).
   PubMed Web of Science ®Google Scholar
• Sessa WC , PritchardK, SeyediN, WangJ, HintzeTH: Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression.Circ. Res.74, 349–353 (1994).
   PubMed Web of Science ®Google Scholar
• Blair SN , KohlHWIII, BarlowCE, PaffenbargerRSJr, GibbonsLW, MaceraCA: Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. J. Am. Med. Assoc.273, 1093–1098 (1995).
   PubMed Web of Science ®Google Scholar
• Salonen JT , PuskaP, TuomilehtoJ: Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in eastern finland.Am. J. Epidemiol.115, 526–537 (1982).
   PubMed Web of Science ®Google Scholar
• Davies MJ , ThomasAC: Plaque fissuring – the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Br. Heart J.53, 363–373 (1985).
   PubMedGoogle Scholar
• Higashi Y , SasakiS, KurisuSet al.: Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide.Circulation100, 1194–1202 (1999).
   PubMed Web of Science ®Google Scholar
• Glagov S , WeisenbergE, ZarinsCK, StankunaviciusR, KolettisGJ: Compensatory enlargement of human atherosclerotic coronary arteries.N. Engl. J. Med.316, 1371–1375 (1987).
   PubMed Web of Science ®Google Scholar
• Hambrecht R , HilbrichL, ErbsSet al.: Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.J. Am. Coll. Cardiol.35, 706–713 (2000).
   PubMed Web of Science ®Google Scholar
• Rudic RD , SheselyEG, MaedaN, SmithiesO, SegalSS, SessaWC: Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.J. Clin. Invest.101, 731–736 (1998).
   PubMed Web of Science ®Google Scholar
• Niebauer J , CookeJP: Cardiovascular effects of exercise: role of endothelial shear stress.J. Am. Coll. Cardiol.28, 1652–1660 (1996).
   PubMed Web of Science ®Google Scholar
• Clarkson P , MontgomeryH, MullenMet al.: Exercise training enhances endothelial function in young men.J. Am. Coll. Cardiol.33, 1379–1385 (1999).
   PubMed Web of Science ®Google Scholar
• Langille BL , O‘DonnellF: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent.Science231, 405–407 (1986).
   PubMed Web of Science ®Google Scholar
• Bucher HC , GriffithLE, GuyattGH: Systematic review on the risk and benefit of different cholesterol-lowering interventions.Arterioscler. Thromb. Vasc. Biol.19, 187–195 (1999).
   PubMed Web of Science ®Google Scholar
• Stamler J , WentworthD, NeatonJ: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).J. Am. Med. Assoc.256, 2823–2828 (1986).
   PubMed Web of Science ®Google Scholar
• Brotons C , RiberaA, PerichRet al.: Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study.Atherosclerosis139, 1–9 (1998).
   PubMed Web of Science ®Google Scholar
• Stein E : Laboratory surrogates for anti-atherosclerotic drug development.Am. J. Cardiol.87, 21A–26A (2001).
   PubMed Web of Science ®Google Scholar
• Williams KJ , TabasI: The response-to-retention hypothesis of early atherogenesis.Arterioscler. Thromb. Vasc. Biol.15, 551–561 (1995).
   PubMed Web of Science ®Google Scholar
• Steinberg D : Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a national heart, lung, and blood institute workshop: September 5–6, 1991, Bethesda, Maryland.Circulation85, 2337–2344 (1992).
   PubMed Web of Science ®Google Scholar
• Esterbauer H , RamosP: Chemistry and pathophysiology of oxidation of LDL.Rev. Physiol. Biochem. Pharmacol.127, 31–64 (1996).
   PubMed Web of Science ®Google Scholar
• Steinberg D : Low density lipoprotein oxidation and its pathobiological significance.J. Biol. Chem.272, 20963–20966 (1997).
   PubMed Web of Science ®Google Scholar
• Ok E , BasnakianAG, ApostolovEO, BarriYM, ShahSV: Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease.Kidney. Int.68, 173–178 (2005).
   PubMed Web of Science ®Google Scholar
• Asci G , BasciA, ShahSVet al.: Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells.Nephrology (Carlton)13, 480–486 (2008).
   PubMed Web of Science ®Google Scholar
• Horkko S , SavolainenMJ, KervinenK, KesaniemiYA: Carbamylation-induced alterations in low-density lipoprotein metabolism.Kidney. Int.41, 1175–1181 (1992).
   PubMed Web of Science ®Google Scholar
• Loria V , DatoI, GrazianiF, BiasucciLM: Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.Mediators Inflamm.2008, 135625 (2008).
   PubMed Web of Science ®Google Scholar
• Shao B , OdaMN, OramJF, HeineckeJW: Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.Curr. Opin. Cardiol.21, 322–328 (2006).
   PubMed Web of Science ®Google Scholar
• Malle E , MarscheG, ArnholdJ, DaviesMJ: Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.Biochim. Biophys. Acta1761, 392–415 (2006).
   PubMed Web of Science ®Google Scholar
• Sirpal S : Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease.Clin. Sci.116, 681–695 (2009).
   PubMed Web of Science ®Google Scholar
• Nicholls SJ , HazenSL: Myeloperoxidase and cardiovascular disease.Arterioscler. Thromb. Vasc. Biol.25, 1102–1111 (2005).
   PubMed Web of Science ®Google Scholar
• Wang Z , NichollsSJ, RodriguezERet al.: Protein carbamylation links inflammation, smoking, uremia and atherogenesis.Nat. Med.13, 1176–1184 (2007).
   PubMed Web of Science ®Google Scholar
• Stary HC , ChandlerAB, GlagovSet al.: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association.Arterioscler. Thromb.14, 840–856 (1994).
   PubMed Web of Science ®Google Scholar
• Ridker PM , HennekensCH, BuringJE, RifaiN: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N. Engl. J. Med.342, 836–843 (2000).
   PubMed Web of Science ®Google Scholar
• Lusis AJ : Atherosclerosis.Nature407, 233–241 (2000).
   PubMed Web of Science ®Google Scholar
• Imai T , NishimuraM, NankiT, UmeharaH: [Fractalkine and inflammatory diseases].Nihon Rinsho Meneki Gakkai Kaishi28, 131–139 (2005).
   PubMedGoogle Scholar
• Debette S , BevanS, DartiguesJFet al.: Fractalkine receptor/ligand genetic variants and carotid intima-media thickness.Stroke40, 2212–2214 (2009).
   PubMed Web of Science ®Google Scholar
• McComb JG , RanganathanM, LiuXHet al.: Cx3cl1 up-regulation is associated with recruitment of cx3cr1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema.Am. J. Pathol.173, 949–961 (2008).
   PubMed Web of Science ®Google Scholar
• Moatti D , FaureS, FumeronFet al.: Polymorphism in the fractalkine receptor cx3cr1 as a genetic risk factor for coronary artery disease.Blood97, 1925–1928 (2001).
   PubMed Web of Science ®Google Scholar
• Mosmann TR , SadS: The expanding universe of T-cell subsets: th1, th2 and more.Immunol. Today17, 138–146 (1996).
   PubMedGoogle Scholar
• Villa-Colinayo V , ShiW, AraujoJ, LusisAJ: Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.Curr. Atheroscler. Rep.2, 380–389 (2000).
   PubMedGoogle Scholar
• Celermajer DS , SorensenKE, GeorgakopoulosDet al.: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.Circulation88, 2149–2155 (1993).
   PubMed Web of Science ®Google Scholar
• Kojda G , BeckJK, MeyerW, NoackE: Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium.Br. J. Pharmacol.112, 533–540 (1994).
   PubMed Web of Science ®Google Scholar
• Moreno HJ , ChalonS, UraeAet al.: Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation.Am. J. Physiol.275, H1040–H1045 (1998).
   PubMedGoogle Scholar
• Bonetti PO , PumperGM, HiganoST, HolmesDRJr, KuvinJT, LermanA: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J. Am. Coll. Cardiol.44, 2137–2141 (2004).
   PubMed Web of Science ®Google Scholar
• Kuvin JT , PatelAR, SlineyKAet al.: Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.Am. Heart J.146, 168–174 (2003).
   PubMed Web of Science ®Google Scholar
• De Caterina R : Endothelial dysfunctions: Common denominators in vascular disease.Curr. Opin. Clin. Nutr. Metab. Care3, 453–467 (2000).
   PubMedGoogle Scholar
• Blann A , McCollumC, LipG: Relationship between plasma markers of endothelial cell integrity and the framingham cardiovascular disease risk-factor scores in apparently healthy individuals.Blood Coagul. Fibrinolysis13, 513–518 (2002).
   PubMed Web of Science ®Google Scholar
• Blann AD , LipGY, McCollumCN: Changes in von Willebrand factor and soluble icam, but not soluble vcam, soluble e selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis.Atherosclerosis165, 389–391 (2002).
   PubMed Web of Science ®Google Scholar
• Hamsten A , de Faire U, Walldius G et al.: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet2, 3–9 (1987).
   PubMed Web of Science ®Google Scholar
• Hamsten A , WimanB, de FaireU, BlombackM: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med.313, 1557–1563 (1985).
   PubMed Web of Science ®Google Scholar
• Sobel BE : Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.Circulation99, 2496–2498 (1999).
   PubMed Web of Science ®Google Scholar
• Binder B : Physiology and pathophysiology of the fibrinolytic system.Fibrinolysis9(Suppl. 1), 3–8 (1995).
   Google Scholar
• Macy EM , MeilahnEN, DeclerckPJ, TracyRP: Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies.Arch. Pathol. Lab. Med.117, 67–70 (1993).
   PubMed Web of Science ®Google Scholar
• Eliasson M , EvrinP, LundbladD, AsplundK, RanbyM: Influence of gender, age, and sampling time on plasma fibrinolytic variables and fibrinogen – a population study.Fibrinolysis7, 316–323 (1993).
   Google Scholar
• Nguyen ND , GhaddarH, StinsonV, ChamblessLE, WuKK: ARIC hemostasis study-iv. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk in Communities (ARIC).Thromb. Haemost.73, 256–260 (1995).
   PubMed Web of Science ®Google Scholar
• Woodhouse PR , MeadeTW, KhawKT: Plasminogen activator inhibitor-1, the acute phase response and vitamin c.Atherosclerosis133, 71–76 (1997).
   PubMed Web of Science ®Google Scholar
• Blomback B : Fibrinogen and fibrin – proteins with complex roles in hemostasis and thrombosis.Thromb. Res.83, 1–75 (1996).
   PubMed Web of Science ®Google Scholar
• Kannel WB , D‘AgostinoRB, BelangerAJ: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study.Am. Heart J.113, 1006–1010 (1987).
   PubMed Web of Science ®Google Scholar
• Ma J , HennekensCH, RidkerPM, StampferMJ: A prospective study of fibrinogen and risk of myocardial infarction in the physicians‘ health study.J. Am. Coll. Cardiol.33, 1347–1352 (1999).
   PubMed Web of Science ®Google Scholar
• Woodward M , LoweGD, RumleyA, Tunstall-PedoeH: Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.Eur. Heart J.19, 55–62 (1998).
   PubMed Web of Science ®Google Scholar
• Wu LL : Review of risk factors for cardiovascular diseases.Ann. Clin. Lab. Sci.29, 127–133 (1999).
   PubMed Web of Science ®Google Scholar
• Margaglione M , CappucciG, ColaizzoDet al.: Fibrinogen plasma levels in an apparently healthy general population – relation to environmental and genetic determinants.Thromb. Haemost.80, 805–810 (1998).
   PubMed Web of Science ®Google Scholar
• Cook NS , UbbenD: Fibrinogen as a major risk factor in cardiovascular disease.Trends Pharmacol. Sci.11, 444–451 (1990).
   PubMed Web of Science ®Google Scholar
• Hackam DG , AnandSS: Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.J. Am. Med. Assoc.290, 932–940 (2003).
   PubMed Web of Science ®Google Scholar
• Hansson G : Immune mechanisms in atherosclerosis.Arterioscler. Thromb. Vasc. Biol.21, 1876–1890 (2001).
   PubMed Web of Science ®Google Scholar
• Getz GS : Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis.J. Lipid Res.46, 1–10 (2005).
   PubMedGoogle Scholar
• Parkin J , CohenB: An overview of the immune system.Lancet357, 1777–1789 (2001).
   PubMed Web of Science ®Google Scholar
• Tobias P , CurtissLK: Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: Toll receptors in atherogenesis.J. Lipid Res.46, 404–411 (2005).
   PubMed Web of Science ®Google Scholar
• Urbich C , DimmelerS: CD40 and vascular inflammation.Can. J. Cardiol.20, 681–683 (2004).
   PubMed Web of Science ®Google Scholar
• Phipps RP : Atherosclerosis: the emerging role of inflammation and the CD40–CD40 ligand system.Proc. Natl Acad. Sci. USA97, 6930–6932 (2000).
   PubMed Web of Science ®Google Scholar
• Heeschen C , DimmelerS, HammCWet al.: Soluble cd40 ligand in acute coronary syndromes.N. Engl. J. Med.348, 1104–1111 (2003).
   PubMed Web of Science ®Google Scholar
• MacPhee CH : Lipoprotein-associated phospholipase A2, a potential new risk factor for coronary artery disease and a therapeutic target.Curr. Opin. Pharmacol.1, 121–125 (2001).
   PubMedGoogle Scholar
• MacPhee CH , MooresKE, BoydHFet al.: Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.Biochem. J.338(Pt 2), 479–487 (1999).
   PubMed Web of Science ®Google Scholar
• Prescott SM , ZimmermanGA, StafforiniDM, McIntyreTM: Platelet-activating factor and related lipid mediators.Annu. Rev. Biochem.69, 419–445 (2000).
   PubMed Web of Science ®Google Scholar
• Ostermann G , LangA, HoltzH, RuhlingK, WinklerL, TillU: The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients.Thromb. Res.52, 529–540 (1988).
   PubMed Web of Science ®Google Scholar
• Hurt-Camejo E , AndersenS, StandalRet al.: Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins.Arterioscler. Thromb. Vasc. Biol.17, 300–309 (1997).
   PubMed Web of Science ®Google Scholar
• Hurt-Camejo E , CamejoG: Potential involvement of type ii phospholipase A2 in atherosclerosis.Atherosclerosis132, 1–8 (1997).
   PubMed Web of Science ®Google Scholar
• Chait A , HanCY, OramJF, HeineckeJW: Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease.J. Lipid Res.46, 389–403 (2005).
   PubMed Web of Science ®Google Scholar
• Ridker PM , RifaiN, RoseL, BuringJE, CookNR: Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.N. Engl. J. Med.347, 1557–1565 (2002).
   PubMed Web of Science ®Google Scholar
• Pepys M , HirschfieldG: C-reactive protein: A critical update.J. Clin. Invest.111, 1805–1812 (2001).
   Web of Science ®Google Scholar
• Armani A , BeckerRC: The biology, utilization, and attenuation of c-reactive protein in cardiovascular disease: part I.Am. Heart J.149, 971–976 (2005).
   PubMedGoogle Scholar
• Armani A , BeckerRC: The biology, utilization, and attenuation of c-reactive protein in cardiovascular disease: part ii.Am. Heart J.149, 977–983 (2005).
   PubMed Web of Science ®Google Scholar
• Ridker PM , DanielsonE, FonsecaFAet al.: Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein.N. Engl. J. Med.359, 2195–2207 (2008).
   PubMed Web of Science ®Google Scholar
• Daugherty A , DunnJL, RateriDL, HeineckeJW: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.J. Clin. Invest.94, 437–444 (1994).
   PubMed Web of Science ®Google Scholar
• Brennan M , PennM, Van Lente F et al.: Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med.349, 1595–1604 (2003).
   PubMed Web of Science ®Google Scholar
• Baldus S , HeeschenC, MeinertzTet al.: Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.Circulation108, 1440–1445 (2003).
   PubMed Web of Science ®Google Scholar
• Biasucci LM , D‘OnofrioG, LiuzzoGet al.: Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.J. Am. Coll. Cardiol.27, 611–616 (1996).
   PubMed Web of Science ®Google Scholar
• Gerdes N , SukhovaGK, LibbyP, ReynoldsRS, YoungJL, SchonbeckU: Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.J. Exp. Med.195, 245–257 (2002).
   PubMed Web of Science ®Google Scholar
• Tenger C , SundborgerA, JawienJ, ZhouX: IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells.Arterioscler. Thromb. Vasc. Biol.25, 791–796 (2005).
   PubMed Web of Science ®Google Scholar
• Blankenberg S , LucG, DucimetierePet al.: Interleukin-18 and the risk of coronary heart disease in european men: the prospective epidemiological study of myocardial infarction (prime).Circulation108, 2453–2459 (2003).
   PubMed Web of Science ®Google Scholar
• Blankenberg S , TiretL, BickelCet al.: Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.Circulation106, 24–30 (2002).
   PubMed Web of Science ®Google Scholar
• Frenette PS , WagnerDD: Adhesion molecules – part I.N. Engl. J. Med.334, 1526–1529 (1996).
   PubMed Web of Science ®Google Scholar
• Frenette PS , WagnerDD: Adhesion molecules – part II: blood vessels and blood cells.N. Engl. J. Med.335, 43–45 (1996).
   PubMed Web of Science ®Google Scholar
• Jang Y , LincoffAM, PlowEF, TopolEJ: Cell adhesion molecules in coronary artery disease.J. Am. Coll. Cardiol.24, 1591–1601 (1994).
   PubMed Web of Science ®Google Scholar
• Adams DH , LloydAR: Chemokines: leucocyte recruitment and activation cytokines.Lancet349, 490–495 (1997).
   PubMed Web of Science ®Google Scholar
• Springer T , CybulskiM: Traffic signals on endothelium for leucocytes in health, inflammation, and atherosclerosis. In: Atherosclerosis and Coronary Artery Disease. Fuster V, Ross R, Topol E (Eds). Lippincott-Raven, PA, USA, Chapter29, 511–537 (1996).
   Google Scholar
• Mulvihill NT , FoleyJB, CreanP, WalshM: Prediction of cardiovascular risk using soluble cell adhesion molecules.Eur. Heart J.23, 1569–1574 (2002).
   PubMed Web of Science ®Google Scholar
• Blankenberg S , RupprechtHJ, BickelCet al.: Circulating cell adhesion molecules and death in patients with coronary artery disease.Circulation104, 1336–1342 (2001).
   PubMed Web of Science ®Google Scholar
• Cimminiello C , ToschiV: Atherothrombosis: The role of platelets.Eur. Heart J.20(Suppl. A), A8–A13 (1999).
   Web of Science ®Google Scholar
• Prentice C : Platelets and atherosclerosis.Eur. Heart J.20(Suppl. A), A3–A7 (1999).
   Web of Science ®Google Scholar
• Entman ML BC: Association of neutrophils with platelet aggregates in unstable angina. Should we alter therapy. Circulation94, 1206–1208 (1996).
   PubMed Web of Science ®Google Scholar
• Fateh-Moghadam S , ErselS, BockschWet al.: Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus Type 2.Arterioscler. Thromb. Vasc. Biol.25, 1299–1303 (2005).
   PubMed Web of Science ®Google Scholar
• Maresca G , Di BlasioA, MarchioliR, Di MinnoG: Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol.19, 1368–1377 (1999).
   PubMed Web of Science ®Google Scholar
• Frohlich M , SundM, LowelH, ImhofA, HoffmeisterA, KoenigW: Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (Monica Augsburg survey 1994/95).Eur. Heart J.24(Suppl. A), 1365–1372 (2003).
   PubMed Web of Science ®Google Scholar
• Schwartz SM , deBloisD, O‘BrienER: The intima. Soil for atherosclerosis and restenosis.Circ. Res.77, 445–465 (1995).
   PubMed Web of Science ®Google Scholar
• Schwartz SM , MurryCE: Proliferation and the monoclonal origins of atherosclerotic lesions.Annu. Rev. Med.49, 437–460 (1998).
   PubMed Web of Science ®Google Scholar
• Cercek B , YamashitaM, DimayugaPet al.: Nuclear factor-κb activity and arterial response to balloon injury.Atherosclerosis131, 59–66 (1997).
   PubMed Web of Science ®Google Scholar
• Landry DB , CouperLL, BryantSR, LindnerV: Activation of the NF-κb and Iκb system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.Am. J. Pathol.151, 1085–1095 (1997).
   PubMed Web of Science ®Google Scholar
• Bu DX , ErlW, de MartinR, HanssonGK, YanZQ: Ikkβ-dependent NF-κb pathway controls vascular inflammation and intimal hyperplasia. FASEB J.19, 1293–1295 (2005).
   PubMed Web of Science ®Google Scholar
• Rainer D , HoethM, Hofer-WarbinekR, SchmidL: The transcription factor NF-κb and the regulation of vascular cell function.Arteroscler. Thromb. Vasc. Biol.20, e83–e88 (2000).
   PubMed Web of Science ®Google Scholar
• Lindner V , LappiDA, BairdA, MajackRA, ReidyMA: Role of basic fibroblast growth factor in vascular lesion formation.Circ. Res.68, 106–113 (1991).
   PubMed Web of Science ®Google Scholar
• Fingerle J , JohnsonR, ClowesA, MajeskyM, ReidyM: Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery.Proc. Natl Acad. Sci. USA86, 8412–8416 (1989).
   PubMed Web of Science ®Google Scholar
• Liau G , ChanL: Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence.J. Biol. Chem.264, 10315–10320 (1989).
   PubMed Web of Science ®Google Scholar
• Hamon M , BautersC, McFaddenEPet al.: Restenosis after coronary angioplasty.Eur. Heart J.16(Suppl. I), 33–48 (1995).
   PubMed Web of Science ®Google Scholar
• Davies M , HagenP: Pathobiology of intimal hyperplasia.Br. J. Surg.81, 1254–1269 (1994).
   PubMed Web of Science ®Google Scholar
• Libby P , SchwartzD, BrogiE, TanakaH, ClintonS: A cascade model for restenosis. A special case for atherosclerosis progression.Circulation86, 47–52 (1992).
   PubMed Web of Science ®Google Scholar
• Tell GS , PolakJF, WardBJ, KittnerSJ, SavagePJ, RobbinsJ: Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Sudy. The Cardiovascular Health Study (CHS) collaborative research group.Circulation90, 2905–2908 (1994).
   PubMed Web of Science ®Google Scholar
• Howard G , WagenknechtLE, BurkeGLet al.: Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study.J. Am. Med. Assoc.279, 119–124 (1998).
   PubMed Web of Science ®Google Scholar
• Sanders M : Molecular and cellular concepts in atherosclerosis.Pharmacol. Ther.61, 109–153 (1994).
   PubMed Web of Science ®Google Scholar
• Libby P : Molecular bases of the acute coronary syndromes.Circulation91, 2844–2850 (1995).
   PubMed Web of Science ®Google Scholar

Websites

• NIH Definitions Working Group: NIH Research Activities – Biomarkers and Surrogate Endpoints (2000). www.fda.gov/ohrms/dockets/ac/00/slides/3593S1_03_downing.ppt
   Google Scholar
• PMUSA: Cigarette smoking and disease in smokers (2004). www.philipmorrisusa.com/en/cms/Products/Cigarettes/Health_Issues/Cigarette_Smoking_and_Disease/default.asp
   Google Scholar